ASP Isotopes (ASPI) Stock Price, News & Analysis

Company Overview

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.

Key Stats

• Today's Range: $6.84 to $7.10
• 50-Day Range: $5.21 to $9.62
• 52-Week Range: $1.86 to $10.08
• Volume: 1.21 million shs
• Average Volume: 2.85 million shs
• Market Capitalization: $582.55 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.67
• Consensus Rating: Buy

ASP Isotopes Stock Analysis - MarketRank™

ASP Isotopes scored higher than 12% of companies evaluated by MarketBeat, and ranked 532nd out of 576 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Buy

Consensus Rating

ASP Isotopes has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

ASP Isotopes has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for ASP Isotopes are expected to grow in the coming year, from ($0.24) to ($0.08) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of ASP Isotopes is -11.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of ASP Isotopes is -11.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

ASP Isotopes has a P/B Ratio of 9.65. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

23.57% of the float of ASP Isotopes has been sold short.

Short Interest Ratio / Days to Cover

ASP Isotopes has a short interest ratio ("days to cover") of 4.7.

Change versus previous month

Short interest in ASP Isotopes has recently increased by 3.88%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

ASP Isotopes does not currently pay a dividend.

Dividend Growth

ASP Isotopes does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

23.57% of the float of ASP Isotopes has been sold short.

Short Interest Ratio / Days to Cover

ASP Isotopes has a short interest ratio ("days to cover") of 4.7.

Change versus previous month

Short interest in ASP Isotopes has recently increased by 3.88%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for ASP Isotopes this week, compared to 8 articles on an average week.

Search Interest

15 people have searched for ASPI on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.

MarketBeat Follows

Only 6 people have added ASP Isotopes to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, ASP Isotopes insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,358,502.00 in company stock.

Percentage Held by Insiders

21.40% of the stock of ASP Isotopes is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 16.80% of the stock of ASP Isotopes is held by institutions.

ASPI Stock Analysis - Frequently Asked Questions

How have ASPI shares performed this year?

ASP Isotopes' stock was trading at $4.53 on January 1st, 2025. Since then, ASPI shares have increased by 53.3% and is now trading at $6.9450.

When did ASP Isotopes IPO?

ASP Isotopes (ASPI) raised $5 million in an initial public offering (IPO) on Thursday, November 10th 2022. The company issued 1,300,000 shares at a price of $4.00 per share. Revere Securities acted as the underwriter for the IPO.

How do I buy shares of ASP Isotopes?

Shares of ASPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of ASP Isotopes own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ASP Isotopes investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), Adobe (ADBE), Arista Networks (ANET), ServiceNow (NOW) and e.l.f. Beauty (ELF).

Company Calendar

• Today: 7/04/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Basic Materials
• Industry: CHEM - DIVERSIFD
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:ASPI
• CIK: 1921865
• Web: www.aspisotopes.com
• Phone: 561-709-3034
• Fax: N/A
• Employees: 76
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $6.67
• High Stock Price Target: $11.00
• Low Stock Price Target: $4.50
• Potential Upside/Downside: -4.0%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 3 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.61)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$32.33 million
• Net Margins: -767.86%
• Pretax Margin: -767.84%
• Return on Equity: -88.40%
• Return on Assets: -41.80%

Debt

• Debt-to-Equity Ratio: 0.80
• Current Ratio: 7.21
• Quick Ratio: 7.17

Sales & Book Value

• Annual Sales: $4.41 million
• Price / Sales: 132.22
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.72 per share
• Price / Book: 9.65

Miscellaneous

• Outstanding Shares: 83,875,000
• Free Float: 65,926,000
• Market Cap: $582.51 million
• Optionable: Not Optionable
• Beta: 3.35